Ionis Pharmaceuticals | IONS - Umsatzerlöse





Der Umsatz Veränderung Datum
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Arrowhead Research USD 75.23M 1.49M 2026-06
Astellas Pharma JPY 640.91B 102.98B 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Exelixis USD 628.69M 17.89M 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Kangmei Pharma CNY 1.19B 106M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 14.41B 1.3B 2026-06
OPKO Health USD 124.2M 24.25M 2026-03
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pfizer USD 15.03B 530M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 19.44B 5.18B 2026-06
Tilray USD 217.51M 74.75M 2025-12
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 1.83B 887.63M 2026-06